Tag: hematological malignancies

Pfizer to acquire immuno-oncology company Trillium Therapeutics for $2.2bn

pallavi123- August 27, 2021

US pharma giant Pfizer has agreed to acquire Trillium Therapeutics, a publicly listed Canadian clinical stage immuno-oncology company, for $18.5 per share or $2.26 billion ... Read More

French biotech company Step Pharma raises €35m in a Series B round

pallavi123- March 24, 2021

Step Pharma has raised €35 million in a Series B financing round for advancing STP938, its lead CTPS1 inhibitor into clinical development for the treatment ... Read More

Merck to acquire US biopharma company VelosBio to strengthen oncology pipeline

pharmanewsdaily- November 8, 2020

Merck acquisition of VelosBio : US pharma giant Merck has agreed to acquire VelosBio, a California-based clinical-stage biopharma company, for $2.75 billion in an all-cash ... Read More

Kangpu wraps up phase 1 clinical trial of CRL4-CRBN modulator KPG-818

pharmanewsdaily- October 14, 2019

Chinese pharma company Kangpu Biopharmaceuticals said that it has wrapped up the first-in-human phase 1 clinical trial of CRL4-CRBN modulator KPG-818 in the US. KPG-818 ... Read More